Futurity·4 min read·hard
New drug slows Alzheimer's disease in mice
E
ETH Zurich
✦AI Summary
Researchers at ETH Zurich have developed a chemical compound, 'Compound 10', that slows the progression of Alzheimer's disease in mice. The substance targets the GRK2 enzyme and shows potential anti-aging effects.
Why it matters
This breakthrough offers a potential new therapeutic avenue for treating dementia, though it remains in the early stages of animal testing.
You are free to share this article under the Attribution 4.0 International license.
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The report focuses on scientific findings without sensationalism.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in